AU2024274559A1 - Process and intermediates for the preparation of a p2x3 inhibitor - Google Patents
Process and intermediates for the preparation of a p2x3 inhibitorInfo
- Publication number
- AU2024274559A1 AU2024274559A1 AU2024274559A AU2024274559A AU2024274559A1 AU 2024274559 A1 AU2024274559 A1 AU 2024274559A1 AU 2024274559 A AU2024274559 A AU 2024274559A AU 2024274559 A AU2024274559 A AU 2024274559A AU 2024274559 A1 AU2024274559 A1 AU 2024274559A1
- Authority
- AU
- Australia
- Prior art keywords
- intermediates
- inhibitor
- preparation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/61—Halogen atoms or nitro radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP23174500.1 | 2023-05-22 | ||
| EP23174500 | 2023-05-22 | ||
| PCT/EP2024/063879 WO2024240728A1 (en) | 2023-05-22 | 2024-05-21 | Process and intermediates for the preparation of a p2x3 inhibitor |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU2024274559A1 true AU2024274559A1 (en) | 2026-01-22 |
Family
ID=86497431
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2024274559A Pending AU2024274559A1 (en) | 2023-05-22 | 2024-05-21 | Process and intermediates for the preparation of a p2x3 inhibitor |
Country Status (7)
| Country | Link |
|---|---|
| CN (1) | CN121368584A (en) |
| AR (1) | AR132737A1 (en) |
| AU (1) | AU2024274559A1 (en) |
| IL (1) | IL324769A (en) |
| MX (1) | MX2025013808A (en) |
| TW (1) | TW202509013A (en) |
| WO (1) | WO2024240728A1 (en) |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2608329T3 (en) | 2010-02-03 | 2017-04-07 | Incyte Holdings Corporation | Imidazo [1,2-b] [1,2,4] triazines as c-Met inhibitors |
| WO2016088838A1 (en) | 2014-12-04 | 2016-06-09 | 塩野義製薬株式会社 | Purine derivative and pharmaceutical composition thereof |
| CN110256418B (en) | 2014-12-09 | 2023-01-20 | 拜耳公司 | 1, 3-thiazol-2-yl substituted benzamides |
| EP3976609A1 (en) | 2019-05-31 | 2022-04-06 | Chiesi Farmaceutici S.p.A. | Pyridopyrimidines derivatives as p2x3 inhibitors |
| JP7641917B2 (en) | 2019-05-31 | 2025-03-07 | キエシ・フアルマチエウテイチ・ソチエタ・ペル・アチオニ | Aminoquinazoline Derivatives as P2X3 Inhibitors |
| CA3196335A1 (en) | 2020-11-27 | 2022-06-02 | Chiesi Farmaceutici S.P.A. | Phthalazine derivatives as p2x3 inhibitors |
| KR20230113536A (en) | 2020-11-27 | 2023-07-31 | 키에시 파르마슈티시 엣스. 피. 에이. | (aza)quinoline 4-amine derivatives as P2X3 inhibitors |
| US20240025880A1 (en) | 2020-11-27 | 2024-01-25 | Chiesi Farmaceutici S.P.A. | Amino quinazoline derivatives as p2x3 inhibitors |
-
2024
- 2024-05-21 AU AU2024274559A patent/AU2024274559A1/en active Pending
- 2024-05-21 TW TW113118684A patent/TW202509013A/en unknown
- 2024-05-21 CN CN202480033791.XA patent/CN121368584A/en active Pending
- 2024-05-21 WO PCT/EP2024/063879 patent/WO2024240728A1/en active Pending
- 2024-05-21 AR ARP240101280A patent/AR132737A1/en unknown
-
2025
- 2025-11-18 IL IL324769A patent/IL324769A/en unknown
- 2025-11-18 MX MX2025013808A patent/MX2025013808A/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| IL324769A (en) | 2026-01-01 |
| AR132737A1 (en) | 2025-07-23 |
| WO2024240728A1 (en) | 2024-11-28 |
| TW202509013A (en) | 2025-03-01 |
| MX2025013808A (en) | 2025-12-01 |
| CN121368584A (en) | 2026-01-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2022297768A1 (en) | Process for the preparation of a cyp11a1 inhibitor and intermediates thereof | |
| AU2024274559A1 (en) | Process and intermediates for the preparation of a p2x3 inhibitor | |
| HK40110671A (en) | Process for the preparation of a cyp11a1 inhibitor and intermediates thereof | |
| HK40094162A (en) | Process and intermediates for preparing a jak1 inhibitor | |
| TWI913303B (en) | Process and intermediates for preparing a jak inhibitor | |
| HK40094141A (en) | Process and intermediates for preparing a jak inhibitor | |
| HK40117825A (en) | Processes and intermediates for the preparation of pridopidine | |
| AU2023903189A0 (en) | A Method for the Preparation of Alumina | |
| AU2023900392A0 (en) | A Method For The Preparation Of Alumina | |
| AU2022902866A0 (en) | A Method for the Preparation of Alumina | |
| CA3295422A1 (en) | Methods for the synthesis of complement factor d inhibitors and intermediates thereof | |
| CA3260504A1 (en) | Process and intermediates useful for preparing nirmatrelvir | |
| AU2024332895A1 (en) | Process for the production of estetrol intermediates | |
| CA3298502A1 (en) | Process for the production of estetrol intermediates | |
| HK40121900A (en) | Process for the production of estetrol intermediates | |
| CA3271656A1 (en) | Process for the preparation of lisdexamfetamine | |
| CA3291803A1 (en) | Polymorphs of nek 7 inhibitors | |
| EP4430025A4 (en) | Process and intermediates for preparation of isofetamid | |
| HK40121904A (en) | Synthesis methods and intermediates for the production of remibrutinib | |
| IL317636A (en) | Solid forms of a jak inhibitor and process of preparing the same | |
| CA3278598A1 (en) | Processes and intermediates for preparing tirzepatide | |
| CA3295226A1 (en) | Process for the manufacture of a her2 inhibitor | |
| CA3274794A1 (en) | Processes and intermediates for synthesis of mrtx0902 | |
| CA3288258A1 (en) | Novel b0at1 inhibitor | |
| AU2023417649A1 (en) | Intermediates of sonrotoclax and the method of preparing the same |